FERMENTA vs QMSMEDI: Stock Comparison

Fermenta Biotech Ltd vs QMS Medical Allied Services Ltd

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Fermenta Biotech Ltd shows a higher ROE, a higher dividend yield and lower leverage, while QMS Medical Allied Services Ltd shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Fermenta Biotech Ltd and QMS Medical Allied Services Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, FERMENTA is more favourable on 7 of 13 scored metrics and QMSMEDI on 4These counts are context-free and are not an overall rating.

Key Differences

P/E Ratio
QMSMEDI has a lower P/E
12.43x vs 18.14x
P/B Ratio
QMSMEDI has a lower P/B
1.95x vs 3.14x
EPS
FERMENTA has higher earnings per share
₹24.4 vs ₹5.24
Dividend Yield
FERMENTA has a higher dividend yield
0.62% vs 0.48%
Qtr Sales Growth
QMSMEDI has stronger quarterly sales growth
-0.36% vs -13.1%
Qtr Profit Growth
QMSMEDI has stronger quarterly profit growth
-48.5% vs -62.9%
ROE
FERMENTA has a higher ROE
17.4% vs 10.4%
ROCE
FERMENTA has a higher ROCE
20.4% vs 13.2%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricFERMENTAQMSMEDI
Live Price₹432.05₹110.6
Day Change7.74%2.24%
Volume2.13 L18,570
52-Week High₹479.45₹118.7
52-Week Low₹248.85₹98.05
Distance from 52W High-9.89%-6.82%

Valuation

MetricFERMENTAQMSMEDI
Market Cap₹1,272 Cr
P/E Ratio18.14x12.43x
P/B Ratio3.14x1.95x
EPS₹24.4₹5.24
Book Value₹138₹53.9
Dividend Yield0.62%0.48%

Growth

MetricFERMENTAQMSMEDI
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth-13.1%-0.36%
Qtr Profit Growth-62.9%-48.5%

Profitability & Leverage

MetricFERMENTAQMSMEDI
ROE17.4%10.4%
ROCE20.4%13.2%
Net Margin13.37%0%
Operating Margin19%15%
Debt to Equity0.28x0.65x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricFERMENTAQMSMEDI
Promoter Holding56.47%68.11%
FII Holding0.02%0%
DII Holding0%1.59%
Public Holding33.3% 0.69 pp30.3%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Fermenta Biotech Ltd and QMS Medical Allied Services Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.